92 related articles for article (PubMed ID: 12926327)
1. [Genetic variability of Bordetella pertussis strains. Part I. Current knowledge].
Gzyl A; Augustynowicz E; Gniadek G; Slusarczyk J
Przegl Epidemiol; 2003; 57(1):181-92. PubMed ID: 12926327
[TBL] [Abstract][Full Text] [Related]
2. [Genetic variability of Bordetella pertussis strains. Part II. Perspectives].
Gzyl A; Augustynowicz E; Gniadek G; Slusarczyk J
Przegl Epidemiol; 2003; 57(1):193-200. PubMed ID: 12926328
[TBL] [Abstract][Full Text] [Related]
3. [Molecular genetic characteristics of the B. pertussis strains isolated in different periods of the pertussis epidemic process].
Mazurova IK; Borisova OIu; Kombarova SIu; Zakharova NS; Aleshkin VA
Mol Gen Mikrobiol Virusol; 2005; (4):21-5. PubMed ID: 16334221
[TBL] [Abstract][Full Text] [Related]
4. The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis.
Fiett J; Letowska I; Gniadkowski M; Hryniewicz W
J Microbiol Methods; 2003 Dec; 55(3):651-66. PubMed ID: 14607408
[TBL] [Abstract][Full Text] [Related]
5. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland.
Mooi FR; He Q; van Oirschot H; Mertsola J
Infect Immun; 1999 Jun; 67(6):3133-4. PubMed ID: 10338531
[TBL] [Abstract][Full Text] [Related]
6. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland.
Gzyl A; Augustynowicz E; van Loo I; Slusarczyk J
Vaccine; 2001 Nov; 20(3-4):299-303. PubMed ID: 11672891
[TBL] [Abstract][Full Text] [Related]
7. Bordetella pertussis vaccine strains and circulating isolates in Serbia.
Dakic G; Kallonen T; Elomaa A; Pljesa T; Vignjevic-Krastavcevic M; He Q
Vaccine; 2010 Feb; 28(5):1188-92. PubMed ID: 19945417
[TBL] [Abstract][Full Text] [Related]
8. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates.
Gzyl A; Augustynowicz E; Gniadek G; Rabczenko D; Dulny G; Slusarczyk J
Vaccine; 2004 Jun; 22(17-18):2122-8. PubMed ID: 15149768
[TBL] [Abstract][Full Text] [Related]
9. Comparison of real-time PCR and pyrosequencing for typing Bordetella pertussis toxin subunit 1 variants.
Storm M; Advani A; Pettersson M; Hallander HO; Bondeson K
J Microbiol Methods; 2006 Apr; 65(1):153-8. PubMed ID: 16095736
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice].
Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
Med Dosw Mikrobiol; 2007; 59(2):123-35. PubMed ID: 17929410
[TBL] [Abstract][Full Text] [Related]
11. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y
J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.
Byrne S; Slack AT
BMC Infect Dis; 2006 Mar; 6():53. PubMed ID: 16542440
[TBL] [Abstract][Full Text] [Related]
13. Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis.
Mäkinen J; Viljanen MK; Mertsola J; Arvilommi H; He Q
Emerg Infect Dis; 2001; 7(6):952-8. PubMed ID: 11747721
[TBL] [Abstract][Full Text] [Related]
14. Genetic verification of Bordetella pertussis seed strains used for production of Japanese acellular pertussis vaccines.
Kamachi K; Fukuda T; Han HJ; Toyoizumi-Ajisaka H; Mochida K; Konda T; Horiuchi Y; Arakawa Y;
Biologicals; 2010 Mar; 38(2):290-3. PubMed ID: 20064727
[TBL] [Abstract][Full Text] [Related]
15. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.
Buasri W; Impoolsup A; Boonchird C; Luengchaichawange A; Prompiboon P; Petre J; Panbangred W
BMC Microbiol; 2012 Apr; 12():61. PubMed ID: 22524455
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations].
Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
Med Dosw Mikrobiol; 2007; 59(2):137-47. PubMed ID: 17929411
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999.
Cassiday P; Sanden G; Heuvelman K; Mooi F; Bisgard KM; Popovic T
J Infect Dis; 2000 Nov; 182(5):1402-8. PubMed ID: 11023463
[TBL] [Abstract][Full Text] [Related]
18. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?
Godfroid F; Denoël P; Poolman J
Expert Rev Vaccines; 2005 Oct; 4(5):757-78. PubMed ID: 16221076
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.
Mooi FR; van Oirschot H; Heuvelman K; van der Heide HG; Gaastra W; Willems RJ
Infect Immun; 1998 Feb; 66(2):670-5. PubMed ID: 9453625
[TBL] [Abstract][Full Text] [Related]
20. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.
Fry NK; Neal S; Harrison TG; Miller E; Matthews R; George RC
Infect Immun; 2001 Sep; 69(9):5520-8. PubMed ID: 11500425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
